Treatment of obstructive sleep apnoea

Indian Journal of Medical Research

Volumn 131, Issue 2, 2010, Pages 236-244

  Veasey, Sigrid ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CPAP; Obesity; OSA; Sleepiness; Treatment

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ARMODAFINIL; CLONAZEPAM; DIAZEPAM; DONEPEZIL; INFLIXIMAB; LORAZEPAM; METHADONE; MODAFINIL; NICOTINIC AGENT; OCTREOTIDE; QUETIAPINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE;

ACROMEGALY; CENTRAL SLEEP APNEA SYNDROME; CLINICAL TRIAL; COMORBIDITY; DAYTIME SOMNOLENCE; DISEASE EXACERBATION; DISEASE SEVERITY; ENDOCRINE DISEASE; HEALTH CARE PERSONNEL; HEALTH HAZARD; HUMAN; NONHUMAN; OBESITY; PATIENT ATTITUDE; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; REVIEW; SLEEP APNEA SYNDROME; SOMNOLENCE; SYMPTOM; CARDIOVASCULAR DISEASES; COMPLICATION; ENDOCRINE SYSTEM; FATIGUE; RISK; SLEEP; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOCRINE SYSTEM; FATIGUE; HUMANS; OBESITY; RISK; SLEEP; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 77649313453     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-53.
2. Young T, Finn L, Peppard Pe, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31: 1071-8.
3. Bardwell WA, Ancoli-Israel S, Berry CC, Dimsdale JE. Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: a placebo-controlled study. Psychosom Med 2001; 63: 579-84.
4. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35: 144-7.
5. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 2001; 163: 911-7.
6. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116: 1545-9.
7. Yu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res 1999; 33: 427-32.
8. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001; 120: 887-93.
9. Engleman H, Joffe D. Neuropsychological function in obstructive sleep apnea. Sleep Med Rev 1999; 3: 59-78.
10. Engleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/ hypopnoea syndrome. Thorax 2004; 59: 618-22.
11. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572-5.
12. Borak J, Cieslicki JK, Koziej M, Matuszewski A, Zielinski J. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res 1996; 5: 123-7.
13. Kohler M, Craig S, nicoll D, Leeson P, Davies RJ, Stradling JR. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med 2008; 178: 984-8.
14. Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007; 30: 711-9.
15. Stoohs RA, Knaack L, Blum HC, Janicki J, Hohenhorst W. Differences in clinical features of upper airway resistance syndrome, primary snoring, and obstructive sleep apnea/ hypopnea syndrome. Sleep Med 2008; 9: 121-8.
16. Stradling JR, Smith D, Crosby J. Post-CPAP sleepiness - a specific syndrome? J Sleep Res 2007; 16: 436-8.
17. Marshall NS, Barnes M, Travier N, Campbell AJ, Pierce RJ, Mcevoy RD, et al. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnea: a meta-analysis. Thorax 2006; 61: 430-4.
18. Mulgrew AT, Nasvadi G, Butt A, Cheema R, Fox N, Fleetham JA, et al. Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea. Thorax 2008; 63: 536-41.
19. George CF. Sleep apnoea, alertness, and motor vehicle crashes. Am J Respir Crit Care Med 2007; 176: 954-6.
20. Barbe F, Sunyer J, de la Pena A, Pericas J, Mayoralas LR, Anto JM, et al. Effect of continuous positive airway pressure on the risk of road accidents in sleep apnea patients. Respiration 2007; 74: 44-9.
21. Archbold KH, Giordani B, Ruzicka DL, Chervin RD. Cognitive executive dysfunction in children with mild sleep-disordered breathing. Biol Res Nurs 2004; 5: 168-76.
22. Bass JL, Corwin M, Gozal D, Moore C, nishida H, Parker S, et al. The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics 2004; 114: 805-16.
23. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, et al. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: A randomized controlled study. J Am Geriatr Soc 2008; 56: 2076-81.
24. Valencia-Flores M, Bliwise DL, Guilleminault C, Cilveti R, Clerk A. Cognitive function in patients with sleep apnoea after acute nocturnal nasal continuous positive airway pressure (CPAP) treatment: sleepiness and hypoxemia effects. J Clin Exp Neuropsychol 1996; 18: 197-210.
25. Aloia MS, Arnedt JT, Davis JD, Riggs RL, Byrd D. Neuropsychological sequelae of obstructive sleep apneahypopnea syndrome: a critical review. J Int Neuropsychol Soc 2004; 10: 772-85.
26. Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta regression analysis. Epidemiol Rev 2007; 29: 6-28.
27. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
28. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284: 3015-21.
29. Schwartz AR, Gold AR, Schubert N, Stryzak A, Wise RA, Permutt S, et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991; 144: 494-8.
30. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103: 850-5.
31. Greenburg DL, Lettieri CJ, Eliasson AH. Effects of surgical weight loss on measures of obstructive sleep apnea: a meta-analysis. Am J Med 2009; 122: 535-42.
32. Lin CC, Tsan KW, Chen PJ. The relationship between sleep apnea syndrome and hypothyroidism. Chest 1992; 102: 1663-7.
33. Pelttari L, Rauhala E, Polo O, Hyyppa MT, Kronholm E, Viikari J, et al. Upper airway obstruction in hypothyroidism. J Intern Med 1994; 236: 177-81.
34. Resta O, Pannacciulli N, Di Gioia G, Stefano A, Barbaro MP, De Pergola G. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 2004; 14: 248-53.
35. Skjodt NM, Atkar R, Easton PA. Screening for hypothyroidism in sleep apnea. Am J Respir Crit Care Med 1999; 160: 732-5.
36. Grunstein RR, Sullivan CE. Sleep apnea and hypothyroidism: mechanisms and management. Am J Med 1988; 85: 775-9.
37. Orr WC, Males JL, Imes NK. Myxedema and obstructive sleep apnea. Am J Med 1981; 70: 1061-6.
38. Rajagopal KR, Abbrecht PH, Derderian SS, Pickett C, Hofeldt F, Tellis CJ, et al. Obstructive sleep apnea in hypothyroidism. Ann Intern Med 1984; 101: 491-4.
39. Grunstein R. Obstructive sleep apnoea syndrome and hypothyroidism. Chest 1994; 105: 1296-7.
40. Resta O, Carratu P, Carpagnano GE, Maniscalco M, Di Gioia G, Lacedonia D, et al. Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS). J Endocrinol Invest 2005; 28: 893-8.
41. Grunstein RR, HO KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med 1991; 115: 527-32.
42. Pelttari L, Polo O, Rauhala E, Vuoriluoto J, Aitasalo K, Hyyppa MT, et al. Ncturnal breathing abnormalities in acromegaly after adenomectomy. Clin Endocrinol (Oxf) 1995; 43: 175-82.
43. Shipley JE, Schteingart DE, Tandon R, Starkman MN. Sleep architecture and sleep apnea in patients with Cushing's disease. Sleep 1992; 15: 514-8.
44. Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, et al. Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab 2001; 86: 117-23.
45. Block AJ. Increased severity of sleep apnoea after 3 oz of 80- proof alcohol ingestion in patients with sleep apnea syndrome. Sleep 1983; 6: 164-6.
46. Block AJ, Hellard DW, Slayton PC. Effect of alcohol ingestion on breathing and oxygenation during sleep. Analysis of the influence of age and sex. Am J Med 1986; 80: 595-600.
47. Mitler MM, Dawson A, Henriksen SJ, Sobers M, Bloom FE. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988; 12: 801-5.
48. Taasan VC, Block AJ, Boysen PG, Wynne JW. Alcohol increases sleep apnoea and oxygen desaturation in asymptomatic men. Am J Med 1981; 71: 240-5.
49. Collop NA. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest 1994; 106: 792-9.
50. Nigri DH, Addor G, Franco CA, Martins RC, Gomes MP, Strollo PJ. Alcohol induced apnea. J Clin Sleep Med 2005; 1: 424-6.
51. Pollock JS, Kenny GN. Effects of lorazepam on oxygen saturation before cardiac surgery. Br J Anaesth 1993; 70: 219-20.
52. Freudenmann RW, Sussmuth SD, Wolf RC, Stiller P, Schonfeldt-Lecuona C. Respiratory dysfunction in sleep apnea associated with quetiapine. Pharmacopsychiatry 2008; 41: 119-21.
53. Schuld A, Kraus T, Haack M, Hinze-Selch D, Pollmacher T. Obstructive sleep apnea syndrome induced by clonazepam in a narcoleptic patient with ReM-sleep-behavior disorder. J Sleep Res 1999; 8: 321-2.
54. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med 2008; 9: 425-32.
55. Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev 2007; 11: 35-46.
56. Andersen ML, Tufik S. The effects of testosterone on sleep and sleep-disordered breathing in men: Its bidirectional interaction with erectile function. Sleep Med Rev 2008; 12: 365-79.
57. Liu PY, Yee B, Wishart SM, Jimenez M, Jung DG, Grunstein RR, et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003; 88: 3605-13.
58. Barrett-Connor E, Dam TT, Stone K, Harrison SL, Redline S, Orwoll E. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab 2008; 93: 2602-9.
59. Zamarron C, Maceiras F, Gonzalez J, Gomez-Reino JJ. Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor. Respir Med 2004; 98: 123-5.
60. Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 2008; 31: 1207-13.
61. Reichmuth KJ, Austin D, Skatrud JB, young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005; 172: 1590-5.
62. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007; 62: 969-74.
63. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apne. syndrome. Am J Respir Crit Care Med 2004; 169: 156-62.
64. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005; 165: 447-52.
65. Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 2005; 9: 176-80.
66. Sepici V, Tosun A, Kokturk O. Obstructive sleep apnea syndrome as an uncommon cause of fibromyalgia: a case report. Rheumatol Int 2007; 28: 69-71.
67. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003; 163: 565-71.
68. Bedard MA, Montplaisir J, Malo J, Richer F, Rouleau I. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol 1993; 15: 330-41.
69. naegele B, Pepin JL, Levy P, Bonnet C, Pellat J, Feuerstein C. Cognitive executive dysfunction in patients with obstructive sleep apnea syndrome (OSAS) after CPAP treatment. Sleep 1998; 21: 392-7.
70. Feuerstein C, naegele B, Pepin JL, Levy P. Frontal loberelated cognitive functions in patients with sleep apnea syndrome before and after treatment. Acta Neurol Belg 1997; 97: 96-107.
71. Aloia MS, Ilniczky N, Di Dio P, Perlis ML, Greenblatt DW, Giles DE. Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res 2003; 54: 71-6.
72. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904.
73. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-6.
74. Sajkov D, Wang T, Saunders NA, Bune AJ, Mcevoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 152-8.
75. Kessler R, Chaouat A, Weitzenblum E, Oswald M, Ehrhart M, Apprill M, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J 1996; 9: 787-94.
76. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27: 1106-13.
77. Harbison J, O'Reilly P, Mcnicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000; 118: 591-5.
78. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 101: 392-7.
79. Milleron O, Pilliere R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004; 25: 728-34.
80. Doherty LS, Kiely JL, Swan V, Mcnicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127: 2076-84.
81. Kakkar RK, Berry RB. Positive airway pressure treatment for obstructive sleep apnea. Chest 2007; 132: 1057-72.
82. Santamaria J, Iranzo A, Ma Montserrat J, de Pablo J. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Sleep Med Rev 2007; 11: 195-207.
83. Olsen S, Smith S, Oei TP. Adherence to continuous positive airway pressure therapy in obstructive sleep apnea sufferers: A theoretical approach to treatment adherence and intervention. Clin Psychol Rev 2008; 28: 1355-71.
84. Garvey JF, Mcnicholas WT. Continuous positive airway pressure therapy: new generations. Indian J Med Res 2010; 131: 259-66.
85. Gindre L, Gagnadoux F, Meslier N, Gustin JM, Racineux JL. Mandibular advancement for obstructive sleep apnea: Dose effect on apnea, long-term use and tolerance. Respiration 2008; 76: 386-92.
86. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest 1999; 115: 771-81.
87. Yoshida K. Influence of sleep posture on response to oral appliance therapy for sleep apnea syndrome. Sleep 2001; 24: 538-44.
88. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006; 29: 1036-44.
89. Ephros HD, Madani M, Yalamanchili SC. Surgical treatment of snoring and obstructive sleep apnoea. Indian J Med Res 2010; 131: 267-76.
90. Lin HC, Friedman M, Chang HW, Gurpinar B. The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope 2008; 118: 902-8.
91. Elshaug AG, Moss JR, Southcott AM, Hiller JE. Redefining success in airway surgery for obstructive sleep apnea: a meta analysis and synthesis of the evidence. Sleep 2007; 30: 461-7.
92. Liu X, Sood S, Liu H, Horner RL. Opposing muscarinic and nicotinic modulation of hypoglossal motor output to genioglossus muscle in rats in vivo. J Physiol 2005; 565: 965-80.
93. Chan E, Steenland HW, Liu H, Horner RL. Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states. Am J Respir Crit Care Med 2006; 174: 1264-73.
94. Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest 2008; 133: 677-83.
95. Williams SC, Rogers NL, Marshall NS, Leung S, Starmer GA, Grunstein RR. The effect of modafinil following acute CPAP withdrawal: a preliminary study. Sleep Breath 2008; 12: 359-64.
96. Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, et al. Placebo and modafinil effect on sleepiness in obstructive sleep apnoea. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 552-9.
97. Hirshkowitz M, Black J. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study. CNS Drugs 2007; 21: 407-16.
98. Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006; 28: 689-706.
99. Godfrey J. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence. J Psychopharmacol 2009; 23: 194-205.